142 related articles for article (PubMed ID: 23818154)
1. Prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infection.
Townes CL; Ali A; Gross N; Pal D; Williamson S; Heer R; Robson CN; Pickard RS; Hall J
Prostate; 2013 Oct; 73(14):1529-37. PubMed ID: 23818154
[TBL] [Abstract][Full Text] [Related]
2. Secretory leukocyte protease inhibitor protects against severe urinary tract infection in mice.
Rosen AL; Lint MA; Voelker DH; Gilbert NM; Tomera CP; Santiago-Borges J; Wallace MA; Hannan TJ; Burnham C-AD; Hultgren SJ; Kau AL
mBio; 2024 Feb; 15(2):e0255423. PubMed ID: 38270443
[TBL] [Abstract][Full Text] [Related]
3. WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung.
Bingle L; Cross SS; High AS; Wallace WA; Rassl D; Yuan G; Hellstrom I; Campos MA; Bingle CD
Respir Res; 2006 Apr; 7(1):61. PubMed ID: 16600032
[TBL] [Abstract][Full Text] [Related]
4. Re: Prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infection.
Schaeffer EM
J Urol; 2014 Aug; 192(2):430. PubMed ID: 25034997
[No Abstract] [Full Text] [Related]
5. The Immune System Fails to Mount a Protective Response to Gram-Positive or Gram-Negative Bacterial Prostatitis.
Lupo F; Rousseau M; Canton T; Ingersoll MA
J Immunol; 2020 Nov; 205(10):2763-2777. PubMed ID: 33055280
[TBL] [Abstract][Full Text] [Related]
6. Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli.
Tseng CC; Wu JJ; Liu HL; Sung JM; Huang JJ
Am J Kidney Dis; 2002 Apr; 39(4):744-52. PubMed ID: 11920340
[TBL] [Abstract][Full Text] [Related]
7. Infection: Potential protective role of raised PSA in recurrent UTI.
Fenner A
Nat Rev Urol; 2013 Sep; 10(9):495. PubMed ID: 23877721
[No Abstract] [Full Text] [Related]
8. Host-pathogen relationships among Escherichia coli isolates recovered from men with febrile urinary tract infection.
Johnson JR; Scheutz F; Ulleryd P; Kuskowski MA; O'Bryan TT; Sandberg T
Clin Infect Dis; 2005 Mar; 40(6):813-22. PubMed ID: 15736014
[TBL] [Abstract][Full Text] [Related]
9. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
10. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization.
Ohlsson K; Bjartell A; Lilja H
J Androl; 1995; 16(1):64-74. PubMed ID: 7539415
[TBL] [Abstract][Full Text] [Related]
11. A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease.
O'Brien VP; Hannan TJ; Yu L; Livny J; Roberson ED; Schwartz DJ; Souza S; Mendelsohn CL; Colonna M; Lewis AL; Hultgren SJ
Nat Microbiol; 2016 Oct; 2():16196. PubMed ID: 27798558
[TBL] [Abstract][Full Text] [Related]
12. Crude polysaccharides from the seeds of Vaccaria segetalis prevent the urinary tract infection through the stimulation of kidney innate immunity.
Mao X; Guo H; Yao R; Bao L; Sun J; Bao Y; Guo B; Gao Y; Shi Y; Zhang H; Cui X
J Ethnopharmacol; 2020 Oct; 260():112578. PubMed ID: 31962152
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy.
Miyazaki Y; Goto T; Li X; Nakayama K; Okasho K; Takeda M; Mizuno K; Kimura H; Uegaki M; Sumiyoshi T; Teramoto Y; Akamatsu S; Kobayashi T; Ogawa O; Inoue T
Cancer Med; 2023 Feb; 12(3):3328-3342. PubMed ID: 36812122
[TBL] [Abstract][Full Text] [Related]
14. Host-Derived Nitric Oxide and Its Antibacterial Effects in the Urinary Tract.
Svensson L; Poljakovic M; Demirel I; Sahlberg C; Persson K
Adv Microb Physiol; 2018; 73():1-62. PubMed ID: 30262107
[TBL] [Abstract][Full Text] [Related]
15.
Yang J; Ma W; Wu Y; Zhou H; Song S; Cao Y; Wang C; Liu X; Ren J; Duan J; Pei Z; Jin C
Microbiol Spectr; 2021 Dec; 9(3):e0039921. PubMed ID: 34878295
[TBL] [Abstract][Full Text] [Related]
16. Bacterial adherence and humoral immune response in women with symptomatic and asymptomatic urinary tract infection.
Ethel S; Bhat GK; Hegde BM
Indian J Med Microbiol; 2006 Jan; 24(1):30-3. PubMed ID: 16505552
[TBL] [Abstract][Full Text] [Related]
17. Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.
Lin AE; Beasley FC; Olson J; Keller N; Shalwitz RA; Hannan TJ; Hultgren SJ; Nizet V
PLoS Pathog; 2015 Apr; 11(4):e1004818. PubMed ID: 25927232
[TBL] [Abstract][Full Text] [Related]
18. Escherichia coli isolates from patients with bacteremic urinary tract infection are genetically distinct from those derived from sepsis following prostate transrectal biopsy.
Dan M; Yair Y; Samosav A; Gottesman T; Yossepowitch O; Harari-Schwartz O; Tsivian A; Schreiber R; Gophna U
Int J Med Microbiol; 2015; 305(4-5):464-8. PubMed ID: 25963574
[TBL] [Abstract][Full Text] [Related]
19. Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography.
Ulleryd P; Zackrisson B; Aus G; Bergdahl S; Hugosson J; Sandberg T
BJU Int; 1999 Sep; 84(4):470-4. PubMed ID: 10468764
[TBL] [Abstract][Full Text] [Related]
20. War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection.
Drannik AG; Henrick BM; Rosenthal KL
Biochem Soc Trans; 2011 Oct; 39(5):1427-32. PubMed ID: 21936827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
